ILBS joins hand with MAMC to do plasma therapy on COVID-19 patients

For this, Dr Suresh Kumar from Lok Nayak Hospital under the umbrella of Maulana Azad Medical College is identifying patients for this trial.

All donors and recipients would be screened to investigate for other co-morbid conditions and diseases like Hepatitis B or C.

Thereafter, the plasma will be administered to the critically sick COVID-19 patients who will meet the set parameters for the therapy.

These patients are admitted to Lok Nayak Hospital.

Recently, the Delhi government has declared Lok Nayak Hospital as a dedicated centre for the treatment of COVID-19 patients.

Dr Suresh Kumar said: "We will create two groups of 10 COVID-19 patients each.

One set of the group will receive convalescent plasma while another group of patients will get placebo plasma.

Then, we will see the outcomes that how both the group of patients are responding to the therapy.

We are very positive that this method will be very effective for our patients." 

Read Also:  COVID 19: Maulana Azad Medical College PG Medical students to be deployed for duty